PortalPublikationenSurface molecule CD229 as a novel target for the diagnosis a...

Surface molecule CD229 as a novel target for the diagnosis and treatment of multiple myeloma.

Standard

Surface molecule CD229 as a novel target for the diagnosis and treatment of multiple myeloma. / Atanackovic, Djordje; Panse, Jens; Hildebrandt, York; Jadczak, Adam; Kobold, Sebastian; Cao, Yanran; Templin, Julia; Meyer, Sabrina; Reinhard, Henrike; Bartels, Katrin; Lajmi, Nesrine; Zander, Axel R.; Marx, Andreas; Bokemeyer, Carsten; Kröger, Nicolaus.

in: HAEMATOLOGICA, Jahrgang 96, Nr. 10, 10, 2011, S. 1512-1520.

Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Zeitschriftenaufsatz › Forschung › Begutachtung

Harvard

Atanackovic, D, Panse, J, Hildebrandt, Y, Jadczak, A, Kobold, S, Cao, Y, Templin, J, Meyer, S, Reinhard, H, Bartels, K, Lajmi, N, Zander, AR, Marx, A, Bokemeyer, C & Kröger, N 2011, 'Surface molecule CD229 as a novel target for the diagnosis and treatment of multiple myeloma.', HAEMATOLOGICA, Jg. 96, Nr. 10, 10, S. 1512-1520. https://doi.org/10.3324/haematol.2010.036814

APA

Atanackovic, D., Panse, J., Hildebrandt, Y., Jadczak, A., Kobold, S., Cao, Y., Templin, J., Meyer, S., Reinhard, H., Bartels, K., Lajmi, N., Zander, A. R., Marx, A., Bokemeyer, C., & Kröger, N. (2011). Surface molecule CD229 as a novel target for the diagnosis and treatment of multiple myeloma. HAEMATOLOGICA, 96(10), 1512-1520. [10]. https://doi.org/10.3324/haematol.2010.036814

Vancouver

Atanackovic D, Panse J, Hildebrandt Y, Jadczak A, Kobold S, Cao Y et al. Surface molecule CD229 as a novel target for the diagnosis and treatment of multiple myeloma. HAEMATOLOGICA. 2011;96(10):1512-1520. 10. https://doi.org/10.3324/haematol.2010.036814

Bibtex

@article{57b60248b7cb44ccb1889d67f8b6b3c5,
title = "Surface molecule CD229 as a novel target for the diagnosis and treatment of multiple myeloma.",
abstract = "To date, multiple myeloma remains an incurable malignancy due to the persistence of minimal residual disease in the bone marrow. In this setting, monoclonal antibodies against myeloma-specific cell surface antigens represent a promising therapeutic approach, which is however hampered by a lack of appropriate target structures expressed across all pathogenic myeloma cell populations. We, therefore, investigated functionally relevant immunoreceptors specifically associated with myeloma cells as well as their clonogenic precursors.",
keywords = "Humans, Cell Line, Tumor, Gene Expression Regulation, Neoplastic, Gene Expression, Gene Silencing, Antineoplastic Agents/pharmacology, Antigens, CD/genetics/*metabolism, Cell Survival/drug effects/genetics, Cytotoxicity, Immunologic/drug effects/genetics, Lymphocyte Subsets/metabolism, Multiple Myeloma/diagnosis/genetics/*metabolism/therapy, Neoplastic Stem Cells/metabolism, Plasma Cells/metabolism/pathology, Humans, Cell Line, Tumor, Gene Expression Regulation, Neoplastic, Gene Expression, Gene Silencing, Antineoplastic Agents/pharmacology, Antigens, CD/genetics/*metabolism, Cell Survival/drug effects/genetics, Cytotoxicity, Immunologic/drug effects/genetics, Lymphocyte Subsets/metabolism, Multiple Myeloma/diagnosis/genetics/*metabolism/therapy, Neoplastic Stem Cells/metabolism, Plasma Cells/metabolism/pathology",
author = "Djordje Atanackovic and Jens Panse and York Hildebrandt and Adam Jadczak and Sebastian Kobold and Yanran Cao and Julia Templin and Sabrina Meyer and Henrike Reinhard and Katrin Bartels and Nesrine Lajmi and Zander, {Axel R.} and Andreas Marx and Carsten Bokemeyer and Nicolaus Kr{\"o}ger",
year = "2011",
doi = "10.3324/haematol.2010.036814",
language = "English",
volume = "96",
pages = "1512--1520",
journal = "HAEMATOLOGICA",
issn = "0390-6078",
publisher = "Ferrata Storti Foundation",
number = "10",

}

RIS

TY - JOUR

T1 - Surface molecule CD229 as a novel target for the diagnosis and treatment of multiple myeloma.

AU - Atanackovic, Djordje

AU - Panse, Jens

AU - Hildebrandt, York

AU - Jadczak, Adam

AU - Kobold, Sebastian

AU - Cao, Yanran

AU - Templin, Julia

AU - Meyer, Sabrina

AU - Reinhard, Henrike

AU - Bartels, Katrin

AU - Lajmi, Nesrine

AU - Zander, Axel R.

AU - Marx, Andreas

AU - Bokemeyer, Carsten

AU - Kröger, Nicolaus

PY - 2011

Y1 - 2011

N2 - To date, multiple myeloma remains an incurable malignancy due to the persistence of minimal residual disease in the bone marrow. In this setting, monoclonal antibodies against myeloma-specific cell surface antigens represent a promising therapeutic approach, which is however hampered by a lack of appropriate target structures expressed across all pathogenic myeloma cell populations. We, therefore, investigated functionally relevant immunoreceptors specifically associated with myeloma cells as well as their clonogenic precursors.

AB - To date, multiple myeloma remains an incurable malignancy due to the persistence of minimal residual disease in the bone marrow. In this setting, monoclonal antibodies against myeloma-specific cell surface antigens represent a promising therapeutic approach, which is however hampered by a lack of appropriate target structures expressed across all pathogenic myeloma cell populations. We, therefore, investigated functionally relevant immunoreceptors specifically associated with myeloma cells as well as their clonogenic precursors.

KW - Humans

KW - Cell Line, Tumor

KW - Gene Expression Regulation, Neoplastic

KW - Gene Expression

KW - Gene Silencing

KW - Antineoplastic Agents/pharmacology

KW - Antigens, CD/genetics/metabolism

KW - Cell Survival/drug effects/genetics

KW - Cytotoxicity, Immunologic/drug effects/genetics

KW - Lymphocyte Subsets/metabolism

KW - Multiple Myeloma/diagnosis/genetics/metabolism/therapy

KW - Neoplastic Stem Cells/metabolism

KW - Plasma Cells/metabolism/pathology

KW - Humans

KW - Cell Line, Tumor

KW - Gene Expression Regulation, Neoplastic

KW - Gene Expression

KW - Gene Silencing

KW - Antineoplastic Agents/pharmacology

KW - Antigens, CD/genetics/metabolism

KW - Cell Survival/drug effects/genetics

KW - Cytotoxicity, Immunologic/drug effects/genetics

KW - Lymphocyte Subsets/metabolism

KW - Multiple Myeloma/diagnosis/genetics/metabolism/therapy

KW - Neoplastic Stem Cells/metabolism

KW - Plasma Cells/metabolism/pathology

U2 - 10.3324/haematol.2010.036814

DO - 10.3324/haematol.2010.036814

M3 - SCORING: Journal article

VL - 96

SP - 1512

EP - 1520

JO - HAEMATOLOGICA

JF - HAEMATOLOGICA

SN - 0390-6078

IS - 10

M1 - 10

ER -